Article Details
Retrieved on: 2024-03-25 20:07:53
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Tilray Inc. (NASDAQ: TLRY), a company in the pharmaceutical industry focusing on medical cannabis, experiencing a stock price drop, with details on insider trading and institutional investments in the context of fintech and equity securities.
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here